Articles by author - Marika Talabova

Natalizumab in the treatment of pediatric multiple sclerosis.

Talab R, Talabova M, Klzo L.

Case Reports 2012; 33(6): 579-589 PubMed PMID: 23160229  Keywords:  Adult, Antibodies, Monoclonal, Humanized:therapeutic use, Brain:pathology, Drug Resistance, Female, Humans, Magnetic Resonance Imaging, Male, Multiple Sclerosis:drug therapy, Natalizumab, Secondary Prevention, Treatment Outcome, Young Adult,.    Citation

: Pediatric cerebrospinal multiple sclerosis (MS) constitutes about 2-5% of all MS cases. The International Pediatric MS Study Group (IPMS.....

Read abstract  Full text PDF